2025 Volume 24 Issue 3 Pages 197-200
The patient is a 91-year-old woman, 50 years of menopause. She underwent bilateral adnexectomy for suspected left ovarian cancer, both for diagnosis and tumor reduction purposes. Postoperative histopathology revealed stage IIA fallopian tube carcinoma. The patient’s family history included a mother who died of breast cancer, an older sister and a nephew who had prostate cancer, a younger sister who died after treatment for heterochronic bilateral breast cancer, and a younger brother who died of prostate cancer. Additionally, it was discovered that the sister who underwent breast cancer treatment had a pathogenic variant in BRCA2, although this information was not disclosed to the patient. Genetic testing revealed the same BRCA2 pathogenic variant as her sister. Subsequently, surveillance was initiated due to the diagnosis of Hereditary Breast and Ovarian Cancer Syndrome (HBOC), leading to the diagnosis of early-stage breast cancer one month later. This case made us recognize the issue of information sharing among the family of elderly patients with hereditary tumors. Seamless support involving family members was considered even more important.
